Esugliem Tablet 10/5 mg (Empagliflozin, Linagliptin Besilate)
Empagliflozin 10mg · Linagliptin Besylate 6.67mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
MFDS item code 202502936 · Approved 2025.11.13
Improvement of blood sugar control in type 2 diabetes
This medication is used to improve blood sugar control in patients with type 2 diabetes who require combination therapy with empagliflozin and linagliptin, along with diet and exercise.
The recommended starting dose of this medication is once daily with empagliflozin 10 mg/linagliptin 5 mg (equivalent to 6.67 mg of linagliptin besilate). If well-tolerated and additional blood sugar control is needed, the dose can be increased to 25/5 mg (equivalent to 6.67 mg of linagliptin besilate) once daily. This medication can be taken regardless of meals.
This medication contains two components, empagliflozin and linagliptin, used for the treatment of type 2 diabetes. Do not use this medication if you have allergies to empagliflozin, linagliptin, or other ingredients in this medication, if you have type 1 diabetes or diabetic ketoacidosis, or if you are undergoing dialysis. Patients with impaired kidney function should regularly undergo kidney function tests before taking this medication and consult with a doctor if necessary. Patients with heart failure or a history of pancreatitis should use this medication cautiously, and if they experience persistent severe abdominal pain, they should stop taking this medication immediately and seek medical attention. While taking this medication, side effects such as urinary tract infections, genital infections, hypoglycemia, dehydration, and low blood pressure may occur, and if symptoms appear, consult with a healthcare provider. Particularly, elderly patients, those with low blood pressure, and those at risk of fluid volume loss should closely monitor for dehydration or blood pressure changes while on this medication. If taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so dosage adjustments may be necessary. It is advisable for pregnant or breastfeeding women to avoid taking this medication and to consult with a healthcare provider if needed. It is recommended that children under 18 years of age not use this medication as its safety and efficacy have not been confirmed. While taking this medication, caution is advised when driving or operating machinery to prevent accidents caused by hypoglycemia. Store this medication out of reach of children and keep it in the original packaging for safety.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help to maintain the drug's effectiveness and safety.
Flat on both sides with sharp edges, pale yellow triangular film-coated tablet
10 tablets/PTP, 30 tablets/PTP [(10 tablets/PTP × 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 10mg · Linagliptin Besylate 6.67mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin Besylate 6.67mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin Besylate 6.67mg
Tablet · Prescription medication · Combination
Kyunbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin Besylate 6.67mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.